EUVIMEDEUVIMED entdecken
ÄquivalenzstudieMultizentrische StudieOpen Access · CC BY 4.0

Evaluation of the Impact of Universal Mupirocin Decolonization in Intensive Care Units on the Utility of Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Testing

Andrea S Ito iD, Kaitlyn C Reasoner, Sharon K Ong'uti, Edward T Qian iD, Zhiguo Zhao iD, Rebecca A Stern iD, Jeffrey A Freiberg iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciag183 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Andrea S Ito und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Polymerase Chain Reaction, Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Bacteriological Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The reliability of methicillin-resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) nasal swab testing in the context of mupirocin nasal decolonization has been questioned. This study investigated whether the negative predictive value (NPV) of MRSA PCR nasal swab testing following mupirocin decolonization was noninferior to testing prior to decolonization.

Methods

This retrospective cohort study included adult inpatients admitted to intensive care units (ICUs) from February 2023 to August 2024 who underwent both MRSA PCR nasal swab testing and universal mupirocin decolonization. Patients were divided into 3 groups based on timing of PCR testing: prior to receiving any doses of topical mupirocin, no more than 7 days after, or >7 days after a first dose. The primary outcome was the NPV of MRSA PCR nasal swab testing.

Results

A total of 1034 patients were included in the primary analysis; 508 (49.1%) had a MRSA PCR nasal swab collected prior to the start of decolonization and 388 (73.8%) and 138 (26.2%) received nasal swabs > 0 to ≤7 days and >7 days after the start of mupirocin decolonization, respectively. The differences between the NPV of MRSA PCR testing in patients with swabs collected prior versus in patients with swabs collected >0 to ≤7 days and >7 days after the start of mupirocin were 0.3% and –0.4% (1-sided 95% CI −.9% and CI −2.3%), respectively.

Conclusions

The NPV of MRSA PCR nasal swabs is not diminished after mupirocin decolonization. MRSA PCR testing within 7 days of initiation of decolonization is noninferior to testing prior to decolonization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymerase Chain ReactionMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsBacteriological TechniquesPredictive Value of TestsMupirocinRetrospective StudiesTime FactorsIntensive Care UnitsReproducibility of ResultsHumansMaleFemaleMiddle AgedAgedNoseAnti-Bacterial AgentsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Staphylococcus aureusMRSA naresantimicrobial stewardshipinfection preventionmupirocin decolonization

Substanzen

MupirocinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Vanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Andrea S Ito, Edward T Qian, Zhiguo Zhao, Rebecca A Stern, Jeffrey A Freiberg

Zitieren

APA

Ito, A. S., Reasoner, K. C., Ong'uti, S. K., Qian, E. T., Zhao, Z., Stern, R. A., & Freiberg, J. A. (2026). Evaluation of the Impact of Universal Mupirocin Decolonization in Intensive Care Units on the Utility of Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Testing. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag183

Vancouver

Ito AS, Reasoner KC, Ong'uti SK, Qian ET, Zhao Z, Stern RA, et al. Evaluation of the Impact of Universal Mupirocin Decolonization in Intensive Care Units on the Utility of Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Testing. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag183

BibTeX
@article{Ito2026,
  author = {Ito, Andrea S and Reasoner, Kaitlyn C and Ong'uti, Sharon K and Qian, Edward T and Zhao, Zhiguo and Stern, Rebecca A and Freiberg, Jeffrey A},
  title = {Evaluation of the Impact of Universal Mupirocin Decolonization in Intensive Care Units on the Utility of Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Testing},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag183}
}
Kostenlos starten →